We are live on
!
Find out more
Two Seas Capital Portfolio holdings
AUM
$8.68B
Turnover
29.09%
1-Year Est. Return
78.08%
This Fund
S&P 500
This Quarter
Est. Return
+40.35%
1 Year Est. Return
+78.08%
3 Year Est. Return
+344.2%
5 Year Est. Return
+575.95%
10 Year Est. Return
–
AUM
$5.05B
AUM Growth
-$2.11B
(-29%)
Cap. Flow
-$38.2M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
72.54%
Holding
57
New
10
Increased
16
Reduced
15
Closed
10
Avg Time Held Equity + Options
1.1
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1.4
years
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
1.6
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$82.9M |
| 2 |
SharonAI Holdings
SHAZ
|
+$49.5M |
| 3 |
Vistra
VST
|
+$38M |
| 4 |
Sable Offshore Corp
SOC
|
+$36.7M |
| 5 |
SpaceX
SPCX
|
+$35.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Scientific
CORZ
|
+$168M |
| 2 |
Indivior Pharmaceuticals
INDV
|
+$46M |
| 3 |
First Solar
FSLR
|
+$41M |
| 4 |
TeraWulf
WULF
|
+$35.2M |
| 5 |
Esperion Therapeutics
ESPR
|
+$31.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.22% |
| 2 | Healthcare | 22.06% |
| 3 | Technology | 9.84% |
| 4 | Utilities | 5.21% |
| 5 | Materials | 4.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
PUT
iShares Bitcoin Trust
IBIT
$65.5B
| – | – |
-500,000
| Closed | -$19.2M | – |
|
52
PUT
Moderna
MRNA
$85B
| – | – |
-1,100,000
| Closed | -$55.9M | – |
|
53
AdvisorShares Pure US Cannabis ETF
MSOS
$755M
| – | – |
-3,302,409
| Closed | -$15.5M | – |
|
54
CALL
EchoStar
ECHO
$25.3B
| – | – |
-375,000
| Closed | -$43.9M | – |
|
55
TransAlta
TAC
$4.05B
| – | – |
-1,597,900
| Closed | -$20.9M | – |
|
56
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.62B
| – | – |
-1,928,000
| Closed | -$246M | – |
|
57
Nebius Group N.V.
NBIS
$46.7B
| – | – |
-196,475
| Closed | -$20.4M | – |
|
Similar funds
GA
Two Seas Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Two Seas Capital held 57 positions worth $5.05B, down 29% from $7.15B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Two Seas Capital's Q2 2026 filing shows 10 new, 16 increased, 15 reduced and 10 closed positions. Its largest new stake was SpaceX: 208,890 shares worth $35.7M. The largest sale was Core Scientific, an estimated $168M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 70% a quarter earlier, followed by Healthcare and Technology.
- Two Seas Capital's largest Q2 2026 buy was SpaceX: 208,890 shares worth $35.7M.
- Two Seas Capital added most to Nektar Therapeutics in Q2 2026, an estimated $82.9M increase.
- Two Seas Capital's biggest Q2 2026 reduction was Core Scientific, cutting an estimated $168M.
- Two Seas Capital fully exited Esperion Therapeutics in Q2 2026, selling an estimated $31.2M.
- Two Seas Capital's ten largest holdings make up 73% of its $5.05B portfolio in Q2 2026.
- Two Seas Capital opened 10 new positions and closed 10 in Q2 2026.
- Two Seas Capital's portfolio value fell 29% quarter-over-quarter to $5.05B.
Based on Two Seas Capital's 13F filing for Q2 2026, filed 12 Aug 2026.